Table 3. Baseline demographical and clinical characteristics of the enrolled HIV-infected patients.
| Characteristics | Total (n = 950) | With cancer (n = 47) | Without cancer (n = 749) | P |
|---|---|---|---|---|
| Age, yr | 42.4 ± 11.8 | 47.9 ± 9.9 | 42.1 ± 11.8 | < 0.010 |
| Sex (male) | 836 (88.0) | 44 (93.6) | 792 (87.9) | 0.690 |
| Mode of transmission | ||||
| Heterosexual | 520 (57.3) | 24 (52.2) | 496 (57.6) | 0.468 |
| Homosexual | 378 (41.7) | 21 (45.7) | 357 (41.5) | 0.575 |
| IV drug use | 12 (1.3) | 0 | 12 (1.4) | > 0.999 |
| Other blood exposure | 4 (0.4) | 1 (2.2) | 3 (0.3) | 0.188 |
| HBV co-infection | 76 (8.9) | 10 (21.3) | 66 (8.2) | 0.006 |
| HCV co-infection | 43 (5.0) | 4 (8.5) | 39 (4.8) | 0.288 |
| CD4+ T cell count at enrollment, cells/mm2 | ||||
| < 50 | 178 (25) | 12 (27.3) | 166 (24.9) | 0.724 |
| 51–200 | 172 (24.2) | 7 (15.9) | 165 (24.7) | 0.185 |
| 201–349 | 179 (25.2) | 16 (36.4) | 163 (24.4) | 0.078 |
| > 350 | 182 (25.6) | 9 (20.5) | 173 (25.9) | 0.420 |
| CDC categories at enrollment | ||||
| Category A | 396 (53.2) | 21 (45.7) | 375 (53.6) | 0.292 |
| Category B | 118 (15.8) | 11 (23.9) | 107 (15.3) | 0.122 |
| Category C | 231 (31.0) | 14 (30.4) | 217 (31.0) | 0.931 |
Values are expressed as number (%) or mean ± standard deviation.
HIV = human immunodeficiency virus, HBV = hepatitis B virus, HCV = hepatitis C virus, CDC = Centers for Disease Control and Prevention.